y2020.4.1z
@82vgR[HP֌\

y2021.4.1z
@Epembrolizumab 6week
@EFOLFIRI+Cmab
@Eatezorizumab+nab-PTX
@Enal-IRI+5-FU/LV
@EFOLFOX4
  EJoW^LZ
  ECBDCA+VP-16(NEC)
@@ǉAS89vgR[HP֍Čf

y2022.4.1z
  Epembrolizumab+CBDCA+PTX
@ECapeOX+Tmab
@EFOLFIRINOX
@EGEM+CDDP+S-1
@EmFOLFIRINOX
@ETAS-102+BV
@Eatezorizumab+BV
@EPmabP
@@ǉAS98vgR[HP֌f

y2023.4.1z
@EEncorafenib+Binimetinib+Cmab
@Efo}u+GEM+CDDP
@ETAS-102+BV
@EPembrolizumab(MSI+High)
@EStFju
@Enab-PTX(j
@EGEMPij
@@ǉAS105vgR[HP֌f

y2024.4.3z
@Enab-PTX(x)
@Enivolumab(4weeks)(x)
@EAe]Y}u+CBDCA+nab-PTX
@EAe]Y}uPƗÖ@
@EG`ju+Rmab(x)
@EIRI+Pmab(咰)
@ENivolumab+G-SOXÖ@
@Efo}u+g}uÖ@
@EGn[cPƗÖ@
@EyuY}u+ECÖ@
@EycY}u+gXcY}u+Eribulin
@EGEM+CDDP(Aj
@ENivolumab(2weeks)(A)
@ENivolumab(4weeks)(A)
@EyuY}u(A)
y2025.4.1z
@ECBDCA+PEM+ipi+nivo
@EmMeJ
@EyuY}u{GEM+CDDP
@EPembrolizumab+CBDCA+GEM
@EPembrolizumab+CBDCA+weeklyPTX
@Ermr
@EyuY}uiBAAj
@EGEM+CDDP(3TԂ)
@ECBDCA+GEM
@E
@@ǉAS129vgR[HP֌f